Search research articles
Contact Us
Filters
Showing results (431-440 of 435) with videos related to
Page
of 44
Sort By:
You have reached the last page of results.
This site can display upto 435 results.
Acta Neurologica Scandinavica
|
April 3, 2014
Epidemiological characteristics of motor neuron disease in Chinese patients
F Cui, M Liu, Y Chen, et al.
International Journal of Obesity (2005)
|
May 21, 2016
Recovery of brain structural abnormalities in morbidly obese patients after bariatric surgery
Y Zhang, G Ji, M Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2024
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC
H A Yu, C Baik, D-W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study
M Oliveira, C Falato, J M Cejalvo, et al.
Plant Disease
|
January 2, 2025
Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from Regulation
I E Tzanetakis, V Aknadibossian, J Špak, et al.
Page
of 44
Search research articles
Search
Showing results (431-440 of 435) with videos related to
Sort By:
Page
of 44
You have reached the last page of results.
This site can display upto 435 results.
Acta Neurologica Scandinavica
|
April 3, 2014
Epidemiological characteristics of motor neuron disease in Chinese patients
F Cui, M Liu, Y Chen, et al.
International Journal of Obesity (2005)
|
May 21, 2016
Recovery of brain structural abnormalities in morbidly obese patients after bariatric surgery
Y Zhang, G Ji, M Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2024
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC
H A Yu, C Baik, D-W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study
M Oliveira, C Falato, J M Cejalvo, et al.
Plant Disease
|
January 2, 2025
Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from Regulation
I E Tzanetakis, V Aknadibossian, J Špak, et al.
Page
of 44